Drug Data and Databases
August 3, 2026
6 minutes

T-Rezept (T-prescription)

A T-Rezept (T-prescription) is the special numbered form required in Germany to prescribe the teratogenic substances thalidomide, lenalidomide and pomalidomide. Governed by §3a of the Arzneimittelverschreibungsverordnung and tracked through the BfArM T-Register, it enforces a pregnancy-prevention programme, a six-day validity and a strictly limited supply per prescription.

Table of contents
    TL;DR
    • A T-Rezept is a special numbered form for thalidomide, lenalidomide and pomalidomide, the teratogenic IMiDs.
    • Legal basis is §3a AMVV, not the AMG, plus §17 ApBetrO on the pharmacy side. The BfArM runs the T-Register.
    • Validity is six days from issue. Maximum supply is four weeks for women of childbearing potential, twelve weeks otherwise.
    • At most one medicine per form, completed fully, with a pregnancy-prevention programme behind it.
    • Only physicians registered for the T-Register may prescribe; forms are personal and issued by the BfArM.
    • A T-Rezept is not a BtM-Rezept: these substances are not Betäubungsmittel.

    A T-Rezept (T-prescription) is a special, numbered prescription form required in Germany for medicines containing thalidomide, lenalidomide or pomalidomide. These three substances are teratogenic: they cause severe birth defects. The T-Rezept exists so that they are prescribed only under a controlled distribution system, with a pregnancy-prevention programme behind every prescription.

    The regime is narrow and deliberate. Only these three active substances, and their generics, fall under it. A T-Rezept is not a general "special prescription": it is specific to the immunomodulatory drugs (IMiDs) that share thalidomide's teratogenic risk, and it is managed centrally by the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) through the T-Register.

    What is the legal basis?

    The controlling provision is §3a of the Arzneimittelverschreibungsverordnung (AMVV), not the AMG, a distinction worth getting right. §3a Abs. 1 AMVV requires that lenalidomide, pomalidomide and thalidomide be prescribed either on the official numbered BfArM form or as a qualified electronic prescription flagged as a "T-Rezept". The pharmacy side is set in §17 Abs. 2b and 6b of the Apothekenbetriebsordnung (ApBetrO). The BfArM issues the forms, runs the T-Register, and publishes the accompanying announcements.

    What are the rules on a T-Rezept?

    RuleRequirementLegal basis
    SubstancesOnly lenalidomide, pomalidomide or thalidomide, and their generics§3a Abs. 1 AMVV
    Medicines per formAt most one medicine per T-Rezept§3a AMVV
    ValidityUp to six days after the date of issue, or the qualified electronic signature§3a Abs. 4 AMVV
    Maximum supply, women of childbearing potentialA four-week supply§3a Abs. 3 AMVV
    Maximum supply, all other patientsA twelve-week supply§3a Abs. 3 AMVV
    CompletenessThe form must be completed fully and correctly; the prescriber confirms the safety conditions§3a Abs. 2 AMVV
    Pregnancy preventionA pregnancy-prevention programme where required, with information materials handed to the patient§3a Abs. 2 AMVV

    Two figures are the ones most often misremembered. The prescription is valid for six days, not the 28 days of an ordinary prescription, and the maximum quantity depends on the patient: four weeks for a woman of childbearing potential, twelve weeks for everyone else. Only one medicine may be written per form.

    Who may prescribe on a T-Rezept?

    Only physicians registered for the T-Register. Under §3a Abs. 5 AMVV the prescriber must hold the medical information materials for the product, commit in writing to the safety requirements set out in its product information, and have the necessary expertise. Forms are requested from the BfArM against an officially certified copy of the medical licence, are personal to the prescriber, and are numbered. The pregnancy-prevention programme sits behind this: for a woman of childbearing potential it requires effective contraception before, during and after treatment and a negative pregnancy test before each prescription, as set out in the product's programme.

    How does a T-Rezept flow to the pharmacy?

    1. A registered physician confirms the safety conditions, completes the form fully, and prescribes a single thalidomide, lenalidomide or pomalidomide medicine within the applicable supply limit.
    2. The patient presents the T-Rezept at a pharmacy within its six-day validity.
    3. The pharmacy checks completeness and validity, dispenses, and documents the supply under §17 ApBetrO.
    4. The pharmacy transmits the prescription copy to the BfArM, weekly for paper forms or via the electronic confirmation route, so the T-Register can track prescribing and dispensing centrally.

    Is a T-Rezept the same as a BtM-Rezept?

    No, and conflating the two is a common error. A BtM-Rezept covers Betäubungsmittel, substances listed in the annexes of the Betäubungsmittelgesetz, on a three-part yellow form under the BtMVV. Thalidomide, lenalidomide and pomalidomide are not Betäubungsmittel: they appear in no BtMG annex, and a T-Rezept substance is therefore never dispensed on a BtM-Rezept. The two systems share the idea of a controlled, numbered form issued by the BfArM, but they rest on different law and cover different substances for different reasons: abuse and dependence for the BtM regime, teratogenicity for the T-Rezept.

    How is T-Rezept status flagged on pharmazie.com?

    Whether an article requires a T-Rezept is a legal classification you should not have to reconstruct by hand for every PZN. On pharmazie.com it is a structured field.

    • Field: the "T-Rezept" flag in the Rechtsinformationen tab, alongside the neighbouring legal flags Betäubungsmittel, EMA-Zulassung, Medizinprodukt, CMR-Gefahrstoff and Verkehrsfähigkeitsstatus
    • Granularity: per PZN
    • Source: ABDA article master data (ABDATA Pharma-Daten-Service)
    • Updated: daily, with a source and date stamp on every detail page
    • Access: web app, REST API, data export

    One honest limitation: the flag tells you that an article is subject to the T-Rezept requirement, per PZN. It does not reproduce the T-Register workflow, the supply limits or the pregnancy-prevention programme, which live in §3a AMVV and the BfArM materials and remain the authority for how to prescribe and dispense.

    Sources

    Author Image
    Ursula Tschorn
    Ursula Tschorn is CEO of DACON Datenbank Consulting GmbH and has been building pharmaceutical information infrastructure since 1989. She writes on drug data standards, pricing regulation and market access in the DACH region.

    FAQ

    What is a T-Rezept?
    Which medicines need a T-Rezept?
    How long is a T-Rezept valid?
    What is the maximum supply on a T-Rezept?
    Who may prescribe on a T-Rezept?
    Is a T-Rezept a BtM-Rezept?

    Other terms

    Since 1989, over 1,000 customers have placed their trust in our data.

    The most comprehensive drug database for pharma professionals.